Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C103303 |
alitretinoin |
alitretinoin promotes the reaction [RARA protein binds to PRAME protein] | affects binding|increases reaction | 16179254
|
D002794 |
Choline |
Choline affects the expression of PRAME mRNA | affects expression | 17616785
|
D004958 |
Estradiol |
[Progesterone co-treated with Estradiol] results in decreased expression of PRAME mRNA | affects cotreatment|decreases expression | 17404688
|
D011374 |
Progesterone |
[Progesterone co-treated with Estradiol] results in decreased expression of PRAME mRNA | affects cotreatment|decreases expression | 17404688
|
D014212 |
Tretinoin |
PRAME protein results in decreased activity of Tretinoin | decreases activity | 16179254
|
D014212 |
Tretinoin |
Tretinoin promotes the reaction [RARA protein binds to PRAME protein] | affects binding|increases reaction | 16179254
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
2.16 | 11473722 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.90 | 15955085 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.28 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.33 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.43 | 16456186 |
MESH:D001321 |
Autistic Disorder |
|
Choline |
3.33 | 16818868 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.84 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
3.98 | 16197459 16206674 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.95 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.74 | 15665606 15845082 15380490 |
MESH:D001943 |
Breast Neoplasms |
|
alitretinoin |
2.05 | 16344269 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.05 | 19861407 16675129 18497071 14630087 17289903 17261762 17018787 12948864 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
2.05 | 16175315 15562024 17614352 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.05 | 16443354 16873071 16166294 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
5.13 | 16813970 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
5.00 | 16111702 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.77 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
3.14 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
3.14 | 1917145 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
marker/mechanism |
|
| 16179254 |
MESH:D002292 |
Carcinoma, Renal Cell |
marker/mechanism |
|
| 16179254 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
2.37 | 16051514 16096774 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.28 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
3.00 | 18566989 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
5.13 | 16129372 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.77 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
2.79 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
4.19 | 17035595 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
1.83 | 10589399 9664655 17551590 14991402 16925845 9224671 8800419 9142499 9125849 9211117 |
MESH:D002658 |
Developmental Disabilities |
|
Choline |
4.90 | 16818868 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.74 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.98 | 17187935 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
5.08 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
4.22 | 17692515 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
8.14 | 11473722 18566989 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
8.14 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
4.11 | 16134523 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
3.84 | 9664655 16938888 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
3.99 | 17994277 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
3.22 | 17312396 |
MESH:D006258 |
Head and Neck Neoplasms |
marker/mechanism |
|
| 16179254 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.41 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.77 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
3.05 | 14991402 9664655 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.64 | 15709030 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
4.36 | 17088409 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.50 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
5.05 | 16778211 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.89 | 15869954 |
MESH:D007249 |
Inflammation |
|
Progesterone |
2.75 | 15869954 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
3.18 | 16393666 16627594 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
4.25 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
4.27 | 15992940 17551590 |
MESH:D017492 |
Keratosis, Seborrheic |
|
alitretinoin |
6.18 | 16144296 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
2.76 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
3.28 | 15610895 |
MESH:D007938 |
Leukemia |
marker/mechanism |
|
| 16179254 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.92 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
4.07 | 16482212 16932348 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.12 | 16294345 19850784 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.37 | 16331271 16823087 17301526 17339181 19029980 17294898 19225113 17217047 17368321 16140955 16891316 17361223 17506722 16788101 12679006 9834237 16935935 19642359 16766008 17649720 19075265 19035177 15748426 17107899 17712046 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.55 | 9224671 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
2.55 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
2.55 | 16248980 18397230 |
MESH:D008175 |
Lung Neoplasms |
|
alitretinoin |
2.65 | 16413115 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
6.77 | 11408345 16891317 11807958 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
6.77 | 17203775 11408345 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
5.09 | 19453300 |
MESH:D008527 |
Medulloblastoma |
marker/mechanism |
|
| 16179254 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.90 | 17453147 |
MESH:D008545 |
Melanoma |
marker/mechanism |
|
| 16179254 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
1.98 | 16752155 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.91 | 16940565 |
MESH:D009101 |
Multiple Myeloma |
marker/mechanism |
|
| 16179254 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.26 | 17596541 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.55 | 16810080 |
MESH:D009369 |
Neoplasms |
|
alitretinoin |
5.90 | 16946489 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
5.90 | 16946489 16594593 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
4.27 | 17289903 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
11.18 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
11.18 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
3.27 | 9142499 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
8.42 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
8.42 | 17393432 16525653 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
8.42 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
3.20 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
2.56 | 15976015 |
MESH:D017499 |
Porokeratosis |
|
alitretinoin |
6.62 | 16144296 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
4.26 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
3.03 | 16740699 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
4.01 | 16636307 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
5.33 | 16723453 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.50 | 16116481 16283617 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.95 | 18045962 |
MESH:D012509 |
Sarcoma |
marker/mechanism |
|
| 16179254 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
2.75 | 16467112 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.82 | 16503802 15862959 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
1.80 | 17261132 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
3.29 | 16026305 17045167 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
5.30 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
4.14 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.43 | 16040207 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
4.02 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
5.22 | 16752155 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.50 | 16761959 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
4.29 | 16287080 |